![Anthony Pare](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Pare served as the Chief Executive Officer at Bioporto A from 2021 to 2024.
Prior to that, he was the Chief Commercial Officer at Hemanext, Inc. and T2 Biosystems, Inc. He also held the position of VP & General Manager-Global Services at Haemonetics Corp.
In terms of education, he received a graduate degree from George Washington University and an undergraduate degree from Maine Maritime Academy.
| Companies | Position | End |
|---|---|---|
| BIOPORTO A/S | Chief Executive Officer | 2024-01-08 |
| T2 BIOSYSTEMS, INC. | Corporate Officer/Principal | 2021-11-07 |
Hemanext, Inc.
 Hemanext, Inc. Medical SpecialtiesHealth Technology Develops anaerobic storage system that minimizes oxidative damage to red blood cells | Corporate Officer/Principal | - |
| HAEMONETICS CORPORATION | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 6 |
|---|---|
Haemonetics Corp.
 Haemonetics Corp. Medical SpecialtiesHealth Technology Designs, manufactures, markets and services blood processing systems | Health Technology |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Develops anaerobic storage system that minimizes oxidative damage to red blood cells | Health Technology |
Bioporto A/S
 Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Maine Maritime Academy
 Maine Maritime Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
T2 Biosystems, Inc.
 T2 Biosystems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
